Skip to main content

Medical Use of Marijuana

Marijuana, or Cannabis sativa, has been the topic of considerable debate and research over the past few years, especially regarding its therapeutic use. With many states and countries legalizing its medical use, its implications for post-acute and long-term care (PALTC) settings cannot be overlooked. Medical marijuana, containing compounds like THC (tetrahydrocannabinol) and CBD (cannabidiol), has been touted for potential benefits in pain management, appetite stimulation, and more. However, its use among older adults, especially in PALTC environments, demands careful consideration of evidence-based practice, ethical considerations, and regulatory compliance.

Understanding the Clinical Utility of Medical Marijuana

  • Indications: Preliminary studies suggest potential benefits in chronic pain, neuropathy, spasticity in multiple sclerosis, nausea/vomiting due to chemotherapy, and certain seizure disorders. Some anecdotal evidence also cites its role in agitation in dementia and insomnia.
  • Pharmacology and Dosage Forms: Medical marijuana can be administered via various routes: inhalation (smoking or vaporizing), oral (capsules, oils, tinctures), topical, or even as edibles. Each method has its onset, peak, and duration of action.

Strategies for Considered Implementation in PALTC

  • Assessment: A comprehensive review is imperative to ascertain the potential benefits against risks. This involves evaluating the indication, past medical history, potential drug interactions, and patient or family preferences.
  • Regulatory Adherence: It is crucial to understand state and federal regulations, which are evolving and can be intricate. Compliance with documentation, storage, and administration guidelines is non-negotiable.
  • Monitoring and Adverse Effects: Regularly assessing the therapeutic effect, potential side effects (like dizziness, sedation, altered cognition, or psychotomimetic effects), and adjusting dosages or formulations accordingly, is vital.
  • Education and Advocacy: Both healthcare providers and patients/families should be well-informed about potential benefits, risks, and the legal landscape.
  • Ethical Considerations: Especially relevant in patients with impaired decision-making capacity. Informed consent, surrogate decision-makers, and weighing potential benefits against harms play pivotal roles.

Position Statement: Marijuana Use in PALTC